Brind.

A conference involving Gilead Sciences and Bayer was held in Philadelphia on September 10, 2026.

1 report, 1 independent Updated Sep 10

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Philadelphia Gilead Sciences BAYER

Keep exploring

The entities involved

Philadelphia
largest city in Pennsylvania, United States
- The CEO of Arthur J. Gallagher & Co. is based in Philadelphia.04:43
- Sabir, a graduate of Cheyney University, leads the election oversight board in Philadelphia.04:03
Gilead Sciences
American company
- FDA approved lenacapavir (Yeztugo) on August 18, 2025, solidifying the HIV portfolio for Gilead Sciences.Mon 18:04
- Dean Hakanson led U.S. Medical Affairs for the remdesivir launch and served in senior leadership positions at major pharmaceutical companies.Mon 17:32
BAYER
company in Prague, Czechia
- Bill Anderson is confirmed as CEO of BAYER while the US chip selloff deepens, affecting Nasdaq.11:35
- Bayer and BASF varieties used in affected crops are failing, impacting the shared agricultural supply chain.Mon 05:45

Related events

Bayer hosted an event in Bangkok to discuss the future of rice production, involving EVP Matthias Berninger and GIZ representatives.Oct 15
Recursion Pharmaceuticals announced strategic alliances with Bayer, Sanofi, Roche, Merck, and Genentech.Jun 30

Coverage

Newest first; wire copies grouped

Sep 10bioxconomy.com